none6nononeMancarella, Caterina; Calzolari, Linda; Ferrari, Stefano; Donati, Davide; Picci, Piero; Scotlandi, KatiaMancarella, Caterina; Calzolari, Linda; Ferrari, Stefano; Donati, Davide; Picci, Piero; Scotlandi, Kati
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
PURPOSE: The type 1 insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the pathog...
Ewing sarcoma, an aggressive primary bone and soft tissue tumour is characterised by the expression ...
Purpose: Large-scale sequencing studies have indicated that besides genomic alterations, the posttra...
Insulin-like growth factor 2 (IGF2) mRNA-binding protein 3 (IGF2BP3) is an oncofetal protein that bi...
The optimal target and timing of drugs interfering with the insulin-like growth factor (IGF) signali...
Contains fulltext : 175100.pdf (publisher's version ) (Open Access)BACKGROUND: Act...
Tumor microenvironment has emerged as key factor influencing tumor progression and metastatization. ...
ABSTRACT OBJECTIVES: Study the clinical characteristics of patients diagnosed with Ewing family tu...
Ewing sarcoma (EWS) is the second most common bone and soft tissue-associated malignancy in children...
The IGF/IGF-IR system plays a major role in the pathogenesis and progression of Ewing\u2019s sarcoma...
Contains fulltext : 81254.pdf (publisher's version ) (Closed access)Sarcomas are a...
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
PURPOSE: Insulin-like growth factor-II (IGF-II) is an important regulator of tumor growth in breast ...
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
PURPOSE: The type 1 insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the pathog...
Ewing sarcoma, an aggressive primary bone and soft tissue tumour is characterised by the expression ...
Purpose: Large-scale sequencing studies have indicated that besides genomic alterations, the posttra...
Insulin-like growth factor 2 (IGF2) mRNA-binding protein 3 (IGF2BP3) is an oncofetal protein that bi...
The optimal target and timing of drugs interfering with the insulin-like growth factor (IGF) signali...
Contains fulltext : 175100.pdf (publisher's version ) (Open Access)BACKGROUND: Act...
Tumor microenvironment has emerged as key factor influencing tumor progression and metastatization. ...
ABSTRACT OBJECTIVES: Study the clinical characteristics of patients diagnosed with Ewing family tu...
Ewing sarcoma (EWS) is the second most common bone and soft tissue-associated malignancy in children...
The IGF/IGF-IR system plays a major role in the pathogenesis and progression of Ewing\u2019s sarcoma...
Contains fulltext : 81254.pdf (publisher's version ) (Closed access)Sarcomas are a...
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
PURPOSE: Insulin-like growth factor-II (IGF-II) is an important regulator of tumor growth in breast ...
BackgroundThe human insulin-like growth factor 2 mRNA binding proteins 1–3 (IGF2BP1–3, also called I...
PURPOSE: The type 1 insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the pathog...
Ewing sarcoma, an aggressive primary bone and soft tissue tumour is characterised by the expression ...